Management of Ascites in End-Stage Organ Failure

Critical Pre-Escalation Assessment

The American Association for the Study of Liver Diseases recommends verifying that serum sodium is ≥125 mmol/L, creatinine is stable, and the patient is not hypotensive or hypovolemic before increasing furosemide from 40 mg to 80 mg orally while awaiting scheduled paracentesis 1, 2
Serum sodium <120-125 mmol/L is an absolute contraindication to any diuretic dose increase, as it may lead to severe hyponatremia 1, 2
Progressive renal failure or acute kidney injury, indicated by rising creatinine, mandates stopping, not increasing diuretics, to prevent further kidney damage 1, 2
Marked hypovolemia or hypotension, assessed by decreased skin turgor, tachycardia, or systolic BP <90 mmHg, is a contraindication to diuretic escalation, as it may worsen hypotension 1, 2
Worsening hepatic encephalopathy, characterized by any deterioration in mental status, contraindicates escalation, as it may indicate inadequate liver function 1, 2
Anuria, or complete absence of urine output, is an absolute contraindication to diuretic escalation, as it may indicate severe kidney dysfunction 2

The American Association for the Study of Liver Diseases recommends increasing to furosemide 80 mg PO once daily in the morning, maintaining or adding spironolactone 100 mg to preserve the 100:40 ratio, to optimize natriuretic effect while minimizing electrolyte disturbances 1, 2
Single morning dosing maximizes compliance and avoids nocturia, improving patient outcomes 1, 2
The 100:40 ratio maintains normokalemia in cirrhotic patients, reducing the risk of hypokalemia or hyperkalemia 1, 2
Oral administration is preferred over IV in cirrhosis because it avoids acute reductions in glomerular filtration rate associated with intravenous furosemide, reducing the risk of kidney damage 3
Maximum safe dose is 160 mg/day - exceeding this threshold indicates diuretic resistance requiring paracentesis rather than further escalation, as it may lead to adverse effects 1, 2, 3

Monitor daily weights, targeting maximum loss of 0.5 kg/day without peripheral edema, or 1.0 kg/day with peripheral edema, to assess diuretic efficacy and prevent excessive fluid loss 1, 2
Monitor serum sodium, potassium, and creatinine every 3-5 days initially, to assess electrolyte balance and kidney function 1, 2
Monitor blood pressure and signs of hypovolemia, assessing for orthostatic changes, to prevent hypotension and ensure adequate fluid status 1, 2
Monitor mental status, watching for worsening encephalopathy, to assess liver function and prevent hepatic coma 1, 2

Do not escalate beyond 160 mg/day of furosemide, as it may lead to adverse effects and indicates treatment failure, according to the European Association for the Study of the Liver and American Association for the Study of Liver Diseases 1, 2, 3
Stop diuretics immediately if serum sodium drops below 120-125 mmol/L, creatinine rises >0.3 mg/dL from baseline, severe hypokalemia or hyperkalemia develops, or incapacitating muscle cramps occur, to prevent adverse effects 1, 2

Large-volume paracentesis removes fluid in minutes versus days-to-weeks with diuretics, and is the definitive treatment for tense ascites, providing rapid relief from symptoms 1, 2
While increasing furosemide may provide temporary relief, it does nothing to correct the underlying sodium retention that caused ascites formation, highlighting the need for paracentesis in refractory cases 1, 2

If no response occurs within 3-5 days at 80 mg, increase to 120 mg (with spironolactone 200 mg) rather than waiting passively for paracentesis, to optimize diuretic efficacy and prevent treatment delay 1, 2
However, if the patient reaches 160 mg/day without adequate response, further escalation is futile and potentially harmful - expedite the paracentesis instead, to prevent adverse effects and ensure timely treatment 1, 2, 3